Mark Coleman Axsome Therapeutics, Inc. (AXSM) insider trading activity

Mark Coleman is of Axsome Therapeutics, Inc.. Currently has a direct ownership of 48,010 shares of AXSM, which is worth approximately $4.36 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 33,410 shares (Common Stock) at a price of $5.94 per share, resulting in proceeds of $198,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48K

228.84% 3M change

91.3% 12M change

Total Value Held $4.36 Million

Mark Coleman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2024	BUY Exercise of conversion of derivative security	$198,455 $5.94 p/Share	33,410 Added 41.03%	48,010 Common Stock
May 29 2024	SELL Open market or private sale	$394,334 $75.14 p/Share	5,248 Reduced 26.44%	14,600 Common Stock
May 28 2024	SELL Open market or private sale	$394,777 $75.21 p/Share	5,249 Reduced 20.91%	19,848 Common Stock
Sep 15 2023	SELL Open market or private sale	$828,293 $75.19 p/Share	11,016 Reduced 30.5%	25,097 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$40,428 $3.67 p/Share	11,016 Added 23.37%	36,113 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$22,751 $1.3 p/Share	17,501 Added 41.08%	25,097 Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$4,545 $1.3 p/Share	3,496 Added 31.52%	7,596 Common Stock

Mark Coleman

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Value

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM

Account